BioAI

BioAI Health is a biotechnology company that applies world-leading multimodal artificial intelligence to precision medicine — mapping the causal biology of disease, developing digital biomarkers, and identifying novel drug targets to accelerate clinical R&D. Founded in 2020 and headquartered in New Hampshire, USA, BioAI's flagship platform, PredictX, enables AI-based models using clinical trial data to improve drug efficacy and patient outcomes in oncology and other therapeutic areas. The company has established strategic partnerships with pharmaceutical companies, research institutions, and genomic testing organizations, including Genomic Testing Cooperative and Arbele Bio. BioAI's multidisciplinary team brings together expertise in machine learning, medicine, and biology, with a scientific advisory board comprising senior advisors from Johnson & Johnson, AstraZeneca, and leading academic institutions.